PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 19: Articles 9001-9500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Husband's involvement boosts contraceptive use among Ethiopian couples.
  2. Husband-wife communication and contraceptive behaviour in Sri Lanka.
  3. IEC strategy in support of family planning evaluated.
  4. IMAP statement on contraceptive counselling.
  5. IMAP statement on contraceptive efficacy.
  6. IMAP statement on emergency contraception.
  7. Immuno-contraception [editorial]
  8. Immuno-contraception undergoing promising trials.
  9. The impact of family planning on women's lives: expanding the research agenda.
  10. The impact of field worker visits on contraceptive discontinuation in two rural areas of Bangladesh.
  11. The impact of mass media family planning promotion on contraceptive behavior of women in Ghana.
  12. Impact of poor women's participation in credit-based self-employment on their empowerment, fertility, contraceptive use, and fertility desire in rural Bangladesh.
  13. The impact of post-partum redundant use of contraception on contraceptive failure rates.
  14. Impact of recommendations against periconceptional contraceptive pill use.
  15. The impact of socioeconomic setting and program effort on contraceptive prevalence in the Egyptian governorates.
  16. Impact of women's education on fertility and family planning in Egypt.
  17. The impact of women's employment and education on contraceptive use and abortion in Kinshasa, Zaire.
  18. The impact of women's human capital on fertility and contraceptive use in Sub-Saharan Africa. A study of fourteen Sub-Saharan countries.
  19. Implantable contraception.
  20. Implantation, interception and contraception.
  21. Implications of contraceptive practice on future fertility trends in Bangladesh.
  22. Improved utilization of spacing methods -- intrauterine devices (IUDs) and low-dose combined oral contraceptives (OCs) -- through re-orientation training for improving quality of services.
  23. Improving access to quality care in family planning. Eligibility criteria for initiating use of selected methods of contraception: combined oral contraceptives, progestogen only pills, DMPA, Norplant implants and copper IUDs. Draft report. Revised.
  24. Improving compliance with oral contraceptive regimens.
  25. Improving financial sustainability through income generation: an approach for estimating profitability of ultrasound in an Ecuadoran family planning agency.
  26. Improving provider practices: highlights of the workshop "Reduction of Medical Barriers to Contraception", Manila, the Philippines, November 12-14, 1993.
  27. Improving the effectiveness of family planning programmes: the contributions of applied research.
  28. Improving the quality of care in Chinese family planning programme.
  29. INANDEP / Peru Contract No. CI91.66A. An Experiment on Organizational Models and Range of Methods for Family Planning Service Delivery to Rural and Semi-Rural Populations in Two Regions of Peru. Participating agencies: Peru Ministry of Health, Instituto Andino de Estudios en Poblacion y Desarrollo (INANDEP), Population Council / INOPAL II, Development Associates, Instituto Peruano de Paternidad Responsable (INPPARES). Final report. September 1, 1991 - July 31, 1994.
  30. Incorporation of Family Planning in CARE Programs in Western Honduras. Final report. CARE / Honduras, Contract No. CI92.53A, August, 1992 - September, 1994.
  31. Increasing use of contraception by decreasing women's dependence and isolation: credit programs and family planning outreach in Bangladesh.
  32. India. Private medical practitioners promoting family planning. Implications for training and follow-up.
  33. Indicators for measuring the quality of family planning services in Nigeria.
  34. Indigenous perceptions and quality of care of family planning services in Haiti.
  35. The Indonesian family planning movement through charts and pictures 1993/1994. [Gerakan keluarga berencana nasional dalam grafik dan gambar 1993/1994.]
  36. Influence of bowel disease, nutrition, smoking and alcohol on the effectiveness of oral contraception. [Wie Darmerkrankungen, Ernahrung, Rauchen und Alkohol die Wirkung von oralen Kontrazeptiva beeinflussen.]
  37. Influence of socioeconomic and cultural level on the use of contraceptive methods. [Influencia del nivel socioeconomico y cultural en el uso de metodos anticonceptivos.]
  38. Information management for family planning programmes.
  39. Information systems and measurement for assessing program effects: implications for family planning programs in developing countries. Summary of an expert meeting.
  40. Initiation and continuation criteria for use of selected contraceptive methods: 1. continuation criteria for COCs, POPs, DMPA, Norplant implants, and copper IUDs; 2. initiation / continuation criteria for male and female barrier methods; 3. initiation criteria for emergency contraceptive pills (COCs and POPs). Tables of classifications with rationales. Draft.
  41. Initiation of contraception during the postpartum period.
  42. Injectable contraceptives available in country soon.
  43. INOPAL II. Ninth semi-annual report. Operations Research and Technical Assistance in Family Planning and Maternal-Child Health in Latin America and the Caribbean, USAID Contract DPE-3030-Z-00-9019-00, October 1, 1993-March 31, 1994.
  44. An integrated approach to family planning in rural China.
  45. Integrating prevention of HIV and STDs into family planning. HIV / STDs: APHA reports.
  46. Integrating the lactational amenorrhea method into a family planning program in Ecuador.
  47. Integration -- the challenge of incorporating STD services into maternal and child health (MCH), family planning (FP) and primary health care (PHC) settings.
  48. The integration of family planning and childhood immunization services in Togo.
  49. Inter-relationship between programme inputs, socio-economic conditions and family planning performance in Bihar.
  50. The interaction of breastfeeding and contraception in Peru.
  51. Levels of childbearing, contraception and abortion in Brazil: differentials by women's poverty status.
  52. Levels, patterns, and determinants of contraceptive failure in rural Bangladesh.
  53. Lina seeks total ban on contraceptive drug.
  54. Lipids, carbohydrate metabolism and cardiovascular risk in oral contraceptive users.
  55. Lipoprotein alterations from a triphasic oral contraceptive containing ethinyl estradiol and gestodene: a 12-month trial.
  56. Listening to the ideas of adolescents. An important source of knowledge for contraception counselors. [Att lyssna pa ungdomars ideer ... Viktig lardom for radgivare om preventivmedel.]
  57. Literacy of women attending family planning clinics in Virginia and reading levels of brochures on HIV prevention.
  58. Literary review of defaulters in family planning clinics.
  59. The localization and concentration of copper in the fallopian tube in women with or without an intrauterine contraceptive device.
  60. Localization of contraceptive implant capsules for removal.
  61. The long-term demographic role of community-based family planning in rural Bangladesh.
  62. Loss of oral contraceptive efficacy by concurrent antibiotic administration.
  63. Madmuun and murih, effective and comfortable. A summary of findings from family planning research in Egypt, 1988-1993.
  64. Maintaining technical quality of care in the introduction of Cyclofem in a national family planning program: findings from Indonesia.
  65. Making contraceptives more expensive.
  66. Making other contraceptives more available.
  67. In Malaysia, family planning is as simple as ABC.
  68. Male attitudes toward family planning must change [editorial]
  69. Male barriers to family planning: myth or reality?
  70. Male barriers to family planning: myth or reality? Research news, Bolivia.
  71. Male contraception: 1993 and beyond.
  72. Male contraception: ideas for the future.
  73. Male leaders participate in Mrs. Ndere's family planning program. Case scenarios for training and group discussion.
  74. Male motivation and group presentation skills for family planning fieldworkers. Training curriculum for Uganda. [Draft]
  75. Male participation in family planning in China: findings from qualitative research [abstract]
  76. A male pill? Gender discrepancies in contraceptive commitment.
  77. The male role in contraceptive continuation among urban women of Bangladesh.
  78. Management of acceptors: an agenda for effective family planning.
  79. Managing contraceptive pill patients. 8th ed.
  80. Marital fertility pattern and family planning practice.
  81. Marketing and price determination of contraceptives--an economic analysis.
  82. Marketing assessment for the sale of contraceptives in the private sector, Romania.
  83. Maternal and child health / family planning and abortion in Madagascar.
  84. Maternal and child health and family planning: traditional practices harmful to the health of women and children.
  85. Maternal deaths among women with pregnancies outside of family planning in Sichuan, China.
  86. Maximizing access to family planning services.
  87. Maximizing access to quality family planning and reproductive health services.
  88. Measuring the effort levels of family planning programmes. (Profile of 30 programme effort scores, 1982 and 1989)
  89. Measuring the need for contraceptive services: findings from a needs assessment survey.
  90. Measuring the quality of family planning counseling in Ghana: integrating observation, interviews and transcript analysis.
  91. Measuring the quality of family planning counseling in Ghana: integrating observation, interviews and transcript analysis. Project report.
  92. Medical and sociocultural barriers and contraception. [Barreras medicas y socioculturales y anticoncepcion.]
  93. Medical contraindications and issues for consideration in the use of once-a-month injectable contraceptives.
  94. Medical groups and health care providers petition FDA to relabel six oral contraceptives as "morning after pills".
  95. Medical staff and family planning. [Zdravstveni radnici i planiranje porodice.]
  96. Medicinal plants: conception / contraception.
  97. Meeting proceedings: Understanding STDs and the Public Health Approaches to their Control: the Appropriate Role of Family Planning Programs, Rosslyn, Virginia, December 7, 1994.
  98. Meeting women's needs for post-abortion family planning. Report of a Bellagio Technical Working Group.
  99. Men and family planning. [Los varones ante la planificacion familiar.]
  100. Men and family planning: toward a policy of male involvement.
  101. Men and family planning: so, what did they talk about?
  102. Men and family planning: towards a direct male participation strategy.
  103. Men and family planning: what we know.
  104. Men should take part in family planning. An interview with the Grand Mufti.
  105. Men's and women's reproductive and contraceptive decisions: a case study from highland Peru.
  106. Menstrual impact of contraception.
  107. The merging of two campaigns: the impact of complementary family planning promotion interventions in Nigeria.
  108. Metabolic effects of once-a-month combined injectable contraceptives.
  109. Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives.
  110. Methodical and practical reliability of natural family planning (letter) [A termeszetes csaladtervezes modszertani es hasznalati megbizhatosaga.]
  111. National Family Health Survey (MCH and Family Planning), Uttar Pradesh, 1992-93. Summary report.
  112. The national family planning program in Peru. [El programa nacional de planificacion familiar en el Peru.]
  113. The National Family Planning Programme strategic plan, July 1994 - June 1999. Draft.
  114. National family planning service delivery guidelines. Volume 1. Family planning and reproductive health. [Ulusal aile planlamasi hizmet rehberi. Cilt I. Aile planlamasi ve ureme sagligi.]
  115. National family planning service delivery guidelines. Volume 2. Contraceptive methods. [Ulusal aile planlamasi hizmet rehberi. Cilt II. Kontraseptif yontemler.]
  116. National implementation plan for the family planning program in Kenya: strategic planning workshop for implementing agencies, 12-15 June, 1994. Draft report.
  117. The National Program to Prevent Unintended Pregnancy. Clinical challenges in contraception: a program on women with special medical conditions.
  118. Nationalism, race, and gender: the politics of family planning in Zimbabwe, 1957-1990.
  119. Natural family planning [letter]
  120. Natural family planning.
  121. Natural family planning. Attitudes must change.
  122. Natural family planning. It empowers couples.
  123. The natural way. A tropical contraceptive.
  124. The Navrongo Community Health and Family Planning Project phase I trial: developing community participation in community health.
  125. New contraceptive technology for men.
  126. The new contraceptives.
  127. A new contract to improve family planning service delivery.
  128. New family planning priorities in Russia.
  129. New injectable male contraceptive. A styrene maleic anhydride "plug" has few side-effects and is reversible.
  130. New knowledge in the physiology of hormonal contraceptives.
  131. A new look at male contraception.
  132. The new low dose oral contraceptives.
  133. New progestogens in oral contraception.
  134. New prospects for injectable contraceptives. [Nuevas perspectivas para los anticonceptivos inyectables.]
  135. New study highlights complexity of regulations governing contraceptives in Bolivia.
  136. A new way to distribute contraceptives.
  137. A new way to distribute contraceptives.
  138. News in brief: [Anglican Archbishop Desmond Tutu voices strong support for family planning]
  139. News in contraception.
  140. NICHD funds studies of contraceptive vaccines.
  141. Non-aligned movement support for South-South collaboration in the field of population and family planning.
  142. Norplant -- a contraceptive implant.
  143. Norplant contraception at the Rabta Tunis maternity hospital. [Contraception par Norplant a la maternite de la Rabta Tunis.]
  144. Norplant contraceptive acceptability among women in five Asian countries.
  145. Norplant contraceptive subdermal implants: a report on the five-year experience in Bangladesh.
  146. Norplant contraceptive.
  147. The Norplant system: an effective, long term contraceptive of the 20th century.
  148. Note from Estonia: from abortion to contraception. [Note d'Estonie: de l'avortement a la contraception.]
  149. Obstacles impede development of contraceptive vaccine.
  150. Obstacles to family planning.
  151. Official Mexican family planning service standards. [Norma oficial mexicana de los servicios de planificacion familiar.]
  152. Official Mexican standard for family planning services. [Norma Oficial Mexicana de los servicios de planificacion familiar.]
  153. The oldest contraceptive. The lactational amenorrhea method (LAM) and reproductive rights.
  154. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
  155. A One-Day Seminar on Injectable Contraceptives. Final report, English summary. Contract No. CI92.74A, November 1, 1992 - December 31, 1992.
  156. An open letter to Pope John Paul II on the question of contraception. [Advertisement]
  157. Optimal targeting of family planning: a resource allocation model.
  158. Oral contraception and stroke. Evidence from the Royal College of General Practitioners' Oral Contraception Study.
  159. Oral contraception in protein C deficiency. [Orale Kontrazeption bei Protein-C-Mangel.]
  160. Oral contraceptive formulation and ovarian cysts: FDA committee finds no increased risk of follicular enlargement with low-dose monophasic or triphasic preparations.
  161. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
  162. Oral contraceptive use and benign gallbladder disease, revisited.
  163. Oral contraceptive use and mortality during 12 years of follow-up: the Nurses' Health Study.
  164. Oral contraceptive use and risk of myocardial infarction: an Italian case-control study.
  165. Oral contraceptive use and the prognosis of breast cancer.
  166. Oral contraceptive-dependent growth of focal nodular hyperplasia.
  167. Oral contraceptives and antibiotics: important considerations for dental practice.
  168. Oral contraceptives and breast cancer prognosis. [Orale Kontrazeptiva und Prognose beim Brustkrebs.]
  169. Oral contraceptives and breast cancer.
  170. Oral contraceptives and prognosis in breast cancer: effects of duration, latency, recency, age at first use and relation to parity and body mass index in young women with breast cancer.
  171. Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus.
  172. Oral contraceptives as an over-the-counter medication.
  173. Oral contraceptives as postcoital prevention -- time to withdraw the requirement of prescription? [P-pille som postkoital prevensjon -- pa tide med reseptfritak?]
  174. Oral contraceptives: 30 vs 20 micrograms of ethinylestradiol. [Anticonceptivos orales: 30 vs. 20 micrograms de etinilestradiol (EE)]
  175. Oral contraceptives: the last decade.
  176. Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women.
  177. Over half way towards replacement fertility. Diversity of contraceptive method mix.
  178. Over-the-counter birth control pills: an overview.
  179. Over-the-counter distribution of oral contraceptives.
  180. An overview of national family planning program in Korea, 1994.
  181. Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial.
  182. Pakistan rapidly institutionalizes the concept and implementation of family planning operations research.
  183. The Palestinian Conference on Population and Family Planning, Palestine Hospital, Cairo, 31 March - 3 April 1994. Final statement and recommendations.
  184. Paradoxes in the costs of family planning in Greece.
  185. Participatory exercises for training in family planning. [Exercices participatifs pour la formation en planning familial.]
  186. Partners in family planning.
  187. Past and present contraceptive behavior of new Soviet immigrant women in Israel.
  188. The pathology of intra-uterine contraceptive devices.
  189. Patterns and determinants of contraceptive discontinuation in Botswana and Zimbabwe.
  190. Pearls for Practice: Contraceptive Choices for Perimenopausal Women [letter]
  191. Peru: reproductive health, abortion and family planning. [Peru: salud reproductiva, aborto y planificacion familiar.]
  192. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
  193. Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
  194. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
  195. Pharmacokinetics of once-a-month injectable contraceptives.
  196. Philippines. Church vs. state: Fidel Ramos and family planning face "Catholic Power".
  197. Place of the IUD in family planning programs. [Place des DIU dans les programmes de planning familial.]
  198. Plan to increase contraceptive prevalence by 25%. Bangladesh goes for sustainable programmes.
  199. The politics of family planning: issues for the future.
  200. Population and family planning in China.
  201. Population and family planning policies in Indonesia: achievements and outstanding issues.
  202. Population Communications International: its role in family planning soap operas.
  203. The Population Council - PRO FAMILIA INOPAL II Project, Subcontract No. CI93.61A. Final report: Technical Assistance for Postpartum Family Planning Training, October 1993 - October 1994. [The Population Council - PRO-FAMILIA Proyecto INOPAL II, Subcontrato No. CI93.61A. Informe final: "Asistencia Tecnica para la Capacitacion en Atencion a la Salud Reproductiva de la Familia", Oct. 93 - Oct. 94.]
  204. The Population Council, INOPAL II final report. Operations Research to Improve Ministry of Health Family Planning Services in Iquitos, Peru, CI90.85A. Participating agencies: Peru Ministry of Health, Vecinos Peru, September 1, 1990 -December 31, 1992.
  205. Population growth and family planning in developing countries. [Bevolkerungswachstum und Familienplanung in Entwicklungslandern.]
  206. Population growth and family planning programmes. Evaluating family planning programmes.
  207. Population policies and family planning.
  208. Population policies and family-planning in Southeast Asia.
  209. Population policy and family planning programmes: contributions from a focus on women.
  210. Population policy in Turkey: family planning and migration between 1960 and 1992.
  211. Population policy must encompass more than family planning services.
  212. Population, family planning, and women's health: finding and pursuing common goals. Report of a symposium.
  213. The position of Islamic tradition on contraception.
  214. Possible physiological bases for contraceptive techniques in the male.
  215. Post primary school teachers' view point on reproductive health and contraceptive practice among schoolgirls in Port Harcourt, Nigeria.
  216. Post-abortion family planning: factors in individual choice of contraceptive methods.
  217. Post-coital contraceptive activity of crude extracts of Sri Lankan marine red algae.
  218. Postcoital contraception. Has its day come?
  219. Postpartum care and family planning services.
  220. Postpartum contraception.
  221. Postpartum counseling for optimal breastfeeding and use of family planning methods.
  222. Postpartum reproductive behavior: lactation, amenorrhea, sexual activity and contraception. [Comportamiento reproductivo postparto. Lactancia, amenorrea, actividad sexual y anticoncepcion.]
  223. The potential of mild testicular heating as a safe, effective and reversible contraceptive method for men.
  224. Potential side effects of oral contraception: hirsutism and hypertension. [Potencialni vedlejsi ucinky peroralni antikoncepce: hirzutismus a hypertenze.]
  225. A practical approach to antibiotic treatment in women taking oral contraceptives.
  226. A practical guide for prescribing birth control pills.

     

  227. Practical problems which women encounter with available contraception in Australia.
  228. Practice, attitudes and knowledge of Czech and Slovak gynaecologists concerning contraception.
  229. Pre- and perinatal anthropology III: birth control, abortion and infanticide in cross-cultural perspective.
  230. Precocious pregnancy and family planning. [Embarazo precoz y planificacion familiar.]
  231. Preferences and tolerance as determinants of contraceptive acceptability.
  232. Pregnancy in systemic lupus erythematosus: contraception, fetal outcome and congenital heart block.
  233. Pregnancy, labor, and delivery care: life-saving skills and family planning programs.
  234. President Mubarak, Turkish Family Planning Foundation receive UN population award.
  235. Previous use of oral contraceptives and spontaneous abortion.
  236. Pricing, Quality of Care, Rumors, and Other Possible Causes of the Loss of Family Planning Clients: a Diagnostic Study in 14 Ecuadorean Cities. Final report. APROFE / Ecuador, Contract No. CI91.86A, October 1, 1991 - November 30, 1992. ["Precios, Calidad de Atencion, Rumores y Otras Posibles Causas de la Caida de Nuevas Usuarias de Planificacion Familiar de APROFE: un Estudio Diagnostico en 14 Ciudades Ecuatorianas". Informe final. APROFE, Asociacion Pro-Bienestar de la Familia Ecuatoriana, Contrato No. CI91.86A, Octubre 1, 1991 - Noviembre 30, 1992.]
  237. Priorities in contraceptive research: the case for barrier methods.
  238. Private fee no barrier to family planning in the Czech Republic.
  239. The private practitioners' family planning project of the Egyptian Junior Medical Doctors Association. Johns Hopkins Center for Communication Programs key findings report.
  240. The private sector and family planning (editorial) [Le secteur prive et la planification familiale.]
  241. Private-sector family planning projects can succeed long-term, even when donor support is withdrawn.
  242. The problem: to generate interest in family planning.
  243. Problems and prospects of implants as a contraceptive method in Bangladesh.
  244. Profile of clients of different providers of family planning services in Egypt. Final report. Social Planning, Analysis and Administration Consultants (SPAAC), the Population Council, Asia and Near East Operations Research and Technical Assistance Project, Sub-Contract No. C192.83A.
  245. Progestasert intrauterine progesterone contraceptive system.
  246. Progesterone as a contraceptive in severe PMS sufferers.
  247. Progestin-only oral contraception: a comprehensive review.
  248. Progestin-releasing intrauterine contraceptive device.
  249. Programme impact on current contraception in Bangladesh.
  250. Projecting contraceptive prevalence from unmet need, and vice versa.
  251. Prolactin injection, a new contraceptive method: experimental study.
  252. Promoting private sector family planning services: initial impact of the Blue Triangle campaign in India.
  253. Proposed approach for medical quality of care in family planning / reproductive health services supported by Pathfinder International.
  254. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.
  255. A prospective study of a monophasic oral contraceptive containing 30 mcg ethinyl oestradiol and 150 mcg desogestrel (Marvelon)
  256. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
  257. Prospects for new hormonal male contraceptives.
  258. Prospects for pharmacological male contraception.
  259. Providing family planning in the workplace. Important factors for institutionalization.
  260. Providing family planning: lessons learned and challenges ahead -- India.
  261. Providing family planning: lessons learned and challenges ahead -- Mexico. [Planificación familiar: lecciones aprendidas y desafíos futuros en México.]
  262. Provincial patterns of contraceptive use in China.
  263. Pseudo-sulfur granules (Pseudo-actinomycotic granules) in intrauterine contraceptive device (IUD) users. [Pseudosulfurgranula (Pseudoaktinomyzesdrusen) bei Intrauterinpessar-Tragerinnen.]
  264. PSI highlights: AIDS prevention, family planning and child survival.
  265. Psychology and family planning.
  266. Public funding and policies for provision of the contraceptive implant, fiscal year 1992.
  267. Public funding for contraceptive services, fiscal year 1992.
  268. A puzzle of will: responding to reproductive tract infections in the context of family planning programs.
  269. Qualitative studies of fertility and family planning in South Africa.
  270. Quality assurance: a manual for NGO family planning services in Bangladesh.
  271. Quality of family planning services and clients satisfaction: the case of FGAE clinic.
  272. The quality of family planning services: a challenge for the 1990s.
  273. Quinacrine family-planning method [letter]
  274. Quinacrine family-planning method [letter]
  275. Quinacrine family-planning method [letter]
  276. Quinacrine family-planning method [letter]
  277. Quinacrine method of family planning [letter]
  278. Quinacrine method of family planning.
  279. Radio promotion of family planning in the Gambia.
  280. Radio promotion of family planning in The Gambia.
  281. Rakhaine community embraces family planning.
  282. Ranging hormones: do hormonal contraceptives ignore human biological variation and evolution?
  283. The rationale and principles of medical standard for clinical contraception.
  284. Re: "Comparison of Recalled and Validated Oral Contraceptive Histories" [letter]
  285. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety.
  286. Reasons for unwanted fertility and barriers to use of family planning services among urban Aymara in Bolivia.
  287. Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA)
  288. Rethinking family planning policy in light of reproductive health research.
  289. Rethinking patient counseling techniques for changing contraceptive use behavior.
  290. The return of fertility after discontinuation of oral contraception in Malaysian women.
  291. Reversible contraception with implants.
  292. Reversible contraception with injections.
  293. A review of "once-a-month" combined injectable contraceptives.
  294. A review of family planning in sub-Saharan Africa.
  295. A review of family planning in Sub-Saharan Africa.
  296. Review of ovulation return upon discontinuation of once-a-month injectable contraceptives.
  297. Review of recent literature on male involvement in family planning. Draft.
  298. A review of three new progestins in oral contraception: norgestimate, desogestrel and gestodene.
  299. The rhythm is off beat: a personal view of Catholic teachings on contraception.
  300. Risk factors for gonorrhoea, syphilis, and trichomonas infections among women attending family planning clinics in Nairobi, Kenya.
  301. Risk factors for pregnancy in adolescents using family planning. [Factores de riesgo de embarazo en adolescentes usuarias de planificacion familiar.]
  302. Risk of breast cancer and oral contraceptives. [Mammakarzinomrisiko und orale Kontrazeptiva.]
  303. Rites and rights: Catholicism and contraception in Chile.
  304. The role of a family planning program in international AIDS care. Questions and answers.
  305. Role of diet on the enterohepatic recycling of estrogen in women taking contraceptive pills.
  306. Role of government family planning workers and health centres as determinants of contraceptive use in Bangladesh.
  307. The role of industry in contraceptive research and development.
  308. Role of long-term (more than ten years') contraception with gestagens in the later development of osteoporosis (answer to question) [Inwieweit wirkt sich eine langfristige (>10 Jahre) Antikonzeption mit reinen Gestagenpraparaten auf die spatere Entstehung einer Osteoporose aus?]
  309. Role of long-term contraception with gestagens in the later development of osteoporosis (answer to question) [Inwieweit wirkt sich eine langfristige (> 10 Jahre) Antikonzeption mit reinen Gestagenpraparaten auf die spatere Entstehung einer Osteoporose aus?]
  310. The role of mass media in family planning promotion in Nigeria.
  311. The role of men in contraceptive decision-making: current knowledge and future implications.
  312. The role of operations research in the Philippines family planning program.
  313. Role of service providers, programme managers and family planning field workers in the sterilization procedure of Bangladesh.
  314. The role of social sciences in the development of contraceptive methods. [El papel de las ciencias sociales en el desarrollo de métodos anticonceptivos.]
  315. The role of the physician in family planning. [Le role du medecin en matiere de planification familiale.]
  316. Roman Catholic Church-sponsored natural family planning services in the United States.
  317. Round table discussion -- intrauterine contraception.
  318. Russia: Fertility, contraception, induced abortion, infant and maternal mortality.
  319. Safe motherhood, family planning and maternal mortality: an Indonesian case study.
  320. Safe provision of oral contraceptives: the effectiveness of systematic laboratory testing in Senegal.
  321. Safety and efficacy of a combined oral contraceptive: gestodene 75 micrograms plus ethinyl estradiol 30 micrograms in Mexican women.
  322. Safety of birth control pills.
  323. The safety of modern contraceptives.
  324. Salmonella may offer contraceptive.
  325. School pupils' knowledge of, need for and use of contraception before and after the AIDS campaigns. Knowledge and sources of information. [Skoleelevers viden om, behov for og brug af praevention for og efter AIDS-kampagnerne. Viden og informationskilder.]
  326. [School students' knowledge of, need for and use of contraception before and after the AIDS campaigns. Sexual activity and contraceptive behavior. [Skoleelevers viden om, behov for og brug af praevention for og efter AIDS-debatten. Seksuel aktivitet og praeventionsvaner.]
  327. Scientific aspects in family planning services.
  328. The Scottish community based family planning and well woman clinic services -- a review.
  329. The search for more choice in contraception.
  330. Search is on for most outstanding family planning workers and clinics.
  331. Secondary school teachers opinion about contraceptive practice and pregnancy among school girls in Port Harcourt, Nigeria: implications for family planning programmes.
  332. Selection bias associated with contraceptive practice in time-to-pregnancy studies.
  333. Serum profiles of oxytocin during oral contraceptive treatment.
  334. Service quality and family planning outreach in Sub-Saharan Africa.
  335. Sex differences in the adaptation of glucose metabolism to short-term fasting: effects of oral contraceptives.
  336. Sex guilt and contraceptive knowledge: interference or justification?
  337. Sex, drugs, relationships, contraception, and fears of disease on a college campus over 17 years.
  338. Sexual activity and contraceptive use amongst teenagers under the age of 15 years [letter]
  339. Sexual behavior and contraceptive practices among university students. [Comportamiento sexual y practicas anticonceptivas del estudiante universitario.]
  340. Sexual behaviour, reproductive health and contraceptive use among adolescents and young adults in Mbale district, Uganda.
  341. Sexual behaviour, social change, and family planning among men and women in Tanzania.
  342. Sexual health: education and counseling perspectives on contraceptive use, HIV and sexuality [editorial]
  343. Sexuality and family planning: a gender analysis. Draft.
  344. Sexuality, discussion and family planning. [Sexualite, parole(s) et planning familial.]
  345. Sexuality, sexual behaviour and contraception in East Germany.
  346. Should family planning include STD services?
  347. Should oral contraceptives be available without prescription? (editorial) [Pitaisiko ehkaisypillerit saada ilman reseptia?]
  348. In situ characterization of leukocytes in the fallopian tube in women with or without an intrauterine contraceptive device.
  349. Situation analyses reveal great variation in quality of services provided at African family planning sites.
  350. Situation analyses reveal great variation in quality of services provided at African family planning sites.
  351. Situation analysis of mother and child health / family planning facilities in Turkey. Ministry of Health / Family Health Training Project.
  352. A situation analysis of public family planning service delivery in Pakistan.
  353. Situation analysis of the Benin family planning program. Preliminary report. [Analyse situationnelle du programme de planification familiale au Benin. Rapport preliminaire.]
  354. A situation analysis of the government run service delivery points for family planning in Indonesia.
  355. Situation analysis study of family planning services in Turkey 1994. Questionnaire 1: Inventory of facilities available and services provided at the service delivery point.
  356. Situation analysis study of family planning services in Turkey 1994. Questionnaire 2: Interview schedule for staff providing family planning or pregnancy termination services at the service delivery point.
  357. Situation analysis study of family planning services in Turkey 1994. Questionnaire 7: Interview schedule for antenatal clients.
  358. Situation analysis study of family planning services in Turkey 1994. Questionnaire 8: Interview schedule for postpartum clients.
  359. Situation analysis study of family planning services in Turkey 1994. Questionnaires 3-4: Observation guide and exit interview for interaction between family planning clients and service providers for outpatient settings.
  360. Situation analysis study of family planning services in Turkey 1994. Questionnaires 5-6: Observation guide for sterilization clients.
  361. Situation analysis study of family planning services in Turkey 1994. Questionnaires 9-10: Observation guide and exit interview for interaction between women who came for pregnancy termination and service providers.
  362. Situation analysis: family planning program. [Analisis situacional: programa de planificacion familiar.]
  363. Slide set for family planning course.
  364. Smoking among oral contraceptive users in Quebec in 1987.
  365. Social communication concerning family planning. Part two: Family planning behaviors. [La communication sociale en matiere de planification familiale. Deuxieme partie: Les comportements de planification familiale.]
  366. Social network influences on contraceptive use among Cameroonian women in voluntary associations.
  367. Social structure, contraceptive availability, and Black fertility decline in Mmabatho / Mafikeng in the Northwest region.
  368. Socialist market economy and the family planning program in China: some theoretical issues reconsidered.
  369. Socio-cultural and economic determinants of contraceptive use in the Lao People's Democratic Republic.
  370. Socio-cultural constraints to family planning in Swaziland.
  371. Socio-economic and demographic factors affecting contraceptive use in Egypt.
  372. Socioeconomic and cultural characteristics of women with unmet need for contraception and the relation to fertility differentials. [Caracteristicas socioeconomicas y culturales de las mujeres con necesidad insatisfecha en anticoncepcion y su relacion con los diferenciales de la fecundidad.]
  373. SOMARC reaches record numbers: theater events in Uganda promote Protector condoms and Pilplan oral contraceptives.
  374. Son preference and demand for family planning.
  375. Sources of contraceptive methods.
  376. Sources of health information regarding contraception and STDs among family planning clinic clients.
  377. Sperm proteins being studied for use in a contraceptive vaccine.
  378. Spermicides and barrier contraception.
  379. Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant.
  380. Sri Lanka Association for Voluntary Surgical Contraception and Family Health.
  381. Starting a village-based family planning worker program in Pakistan.
  382. State family planning and abortion expenditures: their effect on public health.
  383. The state of family planning in Uttar Pradesh, India: a literature synthesis.
  384. State of family planning in Zambia: the dawn of a new era.

     

  385. Status of male contraception: hormonal approach.
  386. STD services in family planning programs.
  387. Sterilization, birth control and population control: the news coverage of "El Mundo", "El Imparcial" and "Claridad".
  388. Strategies for family planning promotion.
  389. Strengthening the Coverage-Extension Strategy of the [family planning program], Ministry of Health, Mexico. Population Council Subcontract No. CI91.89A funded under Contract No. AID / DPE-3030-Z-00-9019-00 (INOPAL II). Final report. November 1, 1991 - June 30, 1994. Desarrollo e Investigacion de la Planificacion Familiar, A.C. (DIPLAF) and the Population Council. [Fortalecimiento de la Estrategia de Extension de Cobertura. Programa de planificacion familiar. Direccion General de Planificacion Familiar. Mexico.]
  390. Study in Turkey leads to integration of abortion and family planning services.
  391. Study of social customs and the acceptability of maternal-child health and family planning services. Vol. 1. [Etude des pratiques sociales et de l'acceptabilite des services de sante materno-infantile et de planification familiale. Vol. 1.]
  392. Study of social customs and the acceptability of maternal-child health and family planning services. Vol. 2. [Etude des pratiques sociales et de l'acceptabilite des services de sante materno-infantile et de planification familiale. Vol. 2.]
  393. A study on the discontinuation and failure of contraception among newly married couples in Shanghai.
  394. Subproject final report: Factors Affecting the Family Planning Program Drop-Out Rate in Bukidnon, Philippines.
  395. Subsidising contraception for young people in Sweden.
  396. Success stories and unintended consequences: the private commercial sector and contraceptive social marketing in Turkey.
  397. The suitability of human chorionic gonadotropin (hCG)-based birth-control vaccines.
  398. Support for research on male hormonal contraception.
  399. Survey of general practitioner instructions to oral contraceptive users.
  400. Symposium: Overpopulation and contraception. Introduction.
  401. Systematization of the information generated by the Ministry of Public Health study on sexual and reproductive behavior and attitudes toward family planning, Metropolitan Region and Region 7 (Olancho) [Sistematizacion de la informacion generada por la investigacion del Ministerio de Salud Publica sobre comportamiento sexual y reproductivo actitudes hacia la planificacion familiar, Region Metropolitana y Region 7 (Olancho)]
  402. Tackling quality of abortion care and postabortion family planning. [Abordando la calidad de atencion del aborto y la planificacion familiar post-aborto.]
  403. Take a health approach to family planning [letter]
  404. Take a health approach to family planning. Offering alternatives [letter]
  405. Taking a bearing -- a regional perspective of family planning clinic provision.
  406. Taking contraceptives to the world's poor.
  407. Tanzania family planning IEC project, Dar es Salaam. Workplan for sentinel clinics assessment, FP radio soap opera monitoring, FP print materials distribution and pretesting of messages for couples.
  408. Tanzania. Communication campaign sparks a growing awareness of family planning needs, methods and practise in Dar es Salaam, Kisarawe and Mwanga, 1994. Draft.
  409. Tanzania. National policy guidelines and standards for family planning service delivery and training. Revised.
  410. Target community foundations to fund family planning.
  411. Target-setting in family planning programs: issues and controversies.
  412. TAT complexes and prothrombin fragment 1+2 in oral contraceptive users.
  413. The TCu 220C, historical aspects and contraceptive efficacy.
  414. Teaching "fertility awareness": how a government family planning program got involved in sexuality.
  415. Teenage pregnancy -- contraceptive use and non-use.
  416. A theoretical framework of collective action for the evaluation of family planning programs.
  417. A Third-World effort on family planning.
  418. Time to throw away your old contraceptives?
  419. Timing of conception and the risk of spontaneous abortion among pregnancies during use of natural family planning.
  420. To use or not use combined hormonal oral contraceptives during lactation.
  421. To what extent were India's population and family planning news stories given prominence by the New York Times?
  422. Touting prevention, Clinton budget seeks increases for family planning.
  423. Towards better health care provision for ethnic minorities in Britain: reproductive health and family planning in the Asian community.
  424. Trade unions hold the key to promoting family planning among workers.
  425. Traditional arts in the service of family planning. Dissemination of evaluation results. Traditional and Modern Media Project. [Les arts traditionnels au service de la planification familiale. Dissemination des resultats de l'evaluation. Projet des Medias Traditionnels et Modernes.]
  426. Traditional birth attendants: family planning awareness, attitudes and advocacy.
  427. Trainers notes. Infection prevention for family planning service programs. Videotape.
  428. Training with video in community family planning programs. A kit.
  429. Transdermal contraceptive delivery system: preclinical development and clinical assessment.
  430. Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives. [Transformacao de adenoma hepatico em carcinoma hepatocelular em pacientes com uso prolongado de contraceptivo oral.]
  431. Transurethral insertion of a vaginal contraceptive suppository into the urinary bladder.
  432. Treatment of ovarian endometriosis using low dose oral contraceptive pills.
  433. Trends and differentials in female contraceptive sterilization in the United States: 1976 and 1988.
  434. Trends in fertility, family planning, and maternal and child health. Results from the Kenya Demographic and Health Survey 1993.
  435. Trends in oral contraceptive use and cigarette smoking. Behavioral Risk Factor Surveillance System, 1982 and 1988.
  436. A trimonthly regimen for oral contraceptives.
  437. Trip report. Focus Group Research Project, Phase II: clients' perspective on contraceptive technology and practice, Kazakhstan, Kyrgyzstan, Turkmenistan, and Uzbekistan (NE-UZB-02). Technical assistance.
  438. Trip report: Mali. Research evaluation activities, AMPPF Project: "Traditional and Modern Media Promote Family Planning" (AF-MAI-02)
  439. Trip report: Zimbabwe. East and South Africa Regional Workshop on Improving Quality of Care and Access to Contraception: Reducing Medical Barriers. Dates of in-country work: January 25 - February 5, 1994.
  440. Tunisian women have greater access than Moroccan women to contraceptives and maternal health care.
  441. Turkey: establishing a legal foundation for family planning. Constitutional and legal changes. Public / private collaboration.
  442. Turkey: moving toward a national strategy for family planning IEC: a needs assessment.
  443. Turkish and Moroccan women: family planning in Flanders and Brussels and in the countries of origin. [Turkse en Marokkaanse vrouwen: gezinsplanning in Vlaanderen en Brussel en in de herkomstlanden.]
  444. Two kinds of production: the evolution of China's family planning policy in the 1980s.
  445. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
  446. Types of family planning methods and marital satisfaction among Ethiopian refugee women in Nairobi, Kenya.
  447. Uganda. Family planning and maternal health: comprehensive clinical skills curriculum. Volume 2: Lesson plans.
  448. UN urges sectors to collaborate in birth control research.
  449. Understanding quality of service in family planning in Nepal.
  450. Understanding the pill: a consumer's guide to oral contraceptives.
  451. The unit cost of family planning.
  452. The United Nations Population Fund and Planned Parenthood proudly present the International Conference on Population and Development.
  453. Unmet need for family planning services exceeds 61 percent in two provinces of rural Cochabamba.
  454. Unsafe abortion and post-abortion family planning in Africa. The Mauritius conference.
  455. Uphold "three stresses" to improve family planning implementation.
  456. US contraceptive prices too high?
  457. Use effectiveness of the Creighton model ovulation method of natural family planning.
  458. The use of contraceptive methods among women seeking a legal abortion.
  459. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
  460. Use of modern and traditional media IEC interventions to improve contraceptive knowledge, attitudes, and practice in Bamako, Mali.
  461. Use of the retinoid pregnancy prevention program in Canada: patterns of contraception use in women treated with isotretinoin and etretinate.
  462. The use of traditional and modern mass media to increase family planning acceptance in Bamako, Mali.
  463. Use of traditional medical practitioners to deliver family planning services in Uttar Pradesh.
  464. The use of traditional methods of contraception among Turkish couples.
  465. Use of true experimental designs for family planning program evaluation: merits, problems and solutions.
  466. User characteristics and oral contraceptive compliance in Egypt.
  467. Using focus-group discussions to explore the role of women's groups (tontines) in family-planning information dissemination in Yaounde, Cameroon.
  468. Using mifepristone in a family planning clinic.
  469. Using operations research findings to develop family planning service expansion project.
  470. Using situation analysis data to assess the functioning of family planning clinics in Nigeria, Tanzania, and Zimbabwe.
  471. Uterine perforation and ileosigmoid fistula caused by an intrauterine contraceptive device. Case report.
  472. Utilisation of family planning services at the teaching hospital in Blantyre, Malawi.
  473. Vaccination for contraception.
  474. Vaccine contraceptives: wisdom, optimism and combatting the potential for abuse. Combatting the potential for abuse.
  475. Vaccine contraceptives: wisdom, optimism and combatting the potential for abuse. Easier to invent than to use wisely.
  476. Vaccine contraceptives: wisdom, optimism and combatting the potential for abuse. Questioning the wisdom in changing a part of the whole.
  477. Vaccine contraceptives: wisdom, optimism and combatting the potential for abuse. The case for anti-sperm immunocontraception.
  478. Vaccine contraceptives: wisdom, optimism and combatting the potential for abuse. The pros and cons: guarded optimism.
  479. A vaccine that prevents pregnancy in women (human chorionic gonadotropin / birth control vaccine)
  480. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
  481. Vaginal contraception since 1984: chemical agents and barrier devices.
  482. The value and use of different contraceptive methods.
  483. Valuing international assistance. An interview with Peng Yu, Vice Minister of the State Family Planning Commission.
  484. Variations in the characteristics of attenders at community family planning clinics.
  485. Very low estrogen-desogestrel contraceptive in perimenopausal hormonal replacement.
  486. The in vitro effect of aspirin on increased whole blood platelet aggregation in oral contraceptive users.
  487. Walking the walk: reproductive health and family planning programs.
  488. What family planning services can do to reduce unsafe abortion.
  489. What has changed? Year-two results of a program to integrate HIV / STD prevention in four family planning associations.
  490. What's happening. New and developing methods of contraception.
  491. What's wrong with contraception? [letter]
  492. What's wrong with contraception? [letter]
  493. When it comes to prescribing emergency contraception, "just do it".
  494. The WHO birth control vaccine [letter]
  495. Who counsels young people on contraception? [Hvem skal radgive unge om praevention?]
  496. Why community participation succeeds in the Indonesian family planning program.
  497. Why natural family planning and not contraception?
  498. Women and family planning. "Now I will tell my daughters".
  499. Women and family planning. Introduction.
  500. Women call for more contraceptive choice.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.